Vivo Bio Tech Secures Compliance Certificate for Regulatory Studies

MT Newswires Live
01/06

Vivo Bio Tech (BOM:511509) said it has received a Certificate of Good Laboratory Practice (GLP) compliance from the National GLP Compliance Monitoring Authority under India's Department of Science & Technology, according to an exchange filing on Monday.

The certification covers non-clinical safety and regulatory studies, including toxicity studies in dogs, carcinogenicity studies, and eye irritation or serious eye damage studies, including in vitro models aligned with international regulatory guidelines.

Shares of the company rose nearly 2% in recent trade.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10